🇺🇸 Conversion to Once-daily Tacrolimus in United States

Conversion to Once-daily Tacrolimus (Conversion to Once-daily Tacrolimus) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Conversion to Once-daily Tacrolimus in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Conversion to Once-daily Tacrolimus approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Conversion to Once-daily Tacrolimus in United States?

Chong Kun Dang Pharmaceutical is the originator. The local marketing authorisation holder may differ — check the official source linked above.